Dynamic distribution and expression in vivo of the human interferon gamma gene delivered by adenoviral vector

doi:10.1186/1471-2407-9-55

BMC Cancer
Volume 9

Viewing options:

Abstract
Full text
PDF (267KB)
Additional files

Associated material:

Related literature:

Articles citing this article
on Google Scholar
on ISI Web of Science
on PubMed Central
Other articles by authors
on Google Scholar

Wu J
Xiao X
Jia H
Chen J
Zhu Y
Zhao P
Lin H
Huang W

on PubMed

Wu J
Xiao X
Jia H
Chen J
Zhu Y
Zhao P
Lin H
Huang W
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Nominate for award

Post to:

Research article

Dynamic distribution and expression in vivo of the human interferon gamma gene delivered by adenoviral vector

Jiangxue Wu¹ , Xia Xiao¹ , Hongyun Jia¹^,3 , Jiemin Chen¹ , Yinghui Zhu¹ , Peng Zhao¹ , Huanxin Lin¹ and Wenlin Huang¹^,2

¹State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, Guangzhou 510060, PR China

²Institute of Microbiology, Chinese Academy of Science, Beijing 100080, PR China

³College of fundamental Medical Science, Guangzhou University of Chinese Medicine, Guangzhou 510006, PR China

author email corresponding author email

BMC Cancer 2009, 9:55doi:10.1186/1471-2407-9-55


Published:	16 February 2009

Abstract

Background

We previously found that r-hu-IFNγ exerts a potent anti-tumor effect on human nasopharyngeal carcinoma xenografts in vivo. Considering the fact that the clinical use of recombinant IFNγ is limited by its short half-life and systemic side effects, we developed a recombinant adenovirus, Ad-IFNγ.

Methods

Dynamic distribution of the adenovirus vector and expression of IFNγ were evaluated by Q-PCR and ELISA after intratumoral administration of Ad-IFNγ into CNE-2 xenografts.

Results

Ad-IFNγ DNA was mainly enriched in tumors where the Ad-IFNγ DNA was injected (P < 0.05, compared to blood or parenchymal organs), as well as in livers (P < 0.05). Concentrations of Ad-IFNγ DNA in other organs and blood were very low. Intratumoral Ad-IFNγ DNA decreased sharply at high concentrations (9 × 10⁵copies/μg tissue DNA), and slowly at lower concentrations (1.7–2.9 × 10⁵copies/μg tissue DNA). IFNγ was detected in the tumors and parenchymal organs. The concentration of IFNγ was highest in the tumor (P < 0.05), followed by the liver and kidney (P < 0.05). High-level intratumoral expression of IFNγ was maintained for at least 7 days, rapidly peaking on day 3 after injection of Ad-IFNγ DNA.

Conclusion

An IFNγ gene delivered by an adenoviral vector achieved high and consistent intratumoral expression. Disseminated Ad-IFNγ DNA and the transgene product were mainly enriched in the liver.